|
Marksans Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
7640.34 Cr.
|
P/BV
|
3.35
|
Book Value (Rs.)
|
50.34
|
|
52 Week High/Low (Rs.)
|
359/169
|
FV/ML
|
1/1
|
P/E(X)
|
20.08
|
|
Bookclosure
|
01/08/2025
|
EPS (Rs.)
|
8.40
|
Div Yield (%)
|
0.47
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 2614.45 | 2174.20 | 1849.62 | 1480.12 | 1368.37 |
| Other Operating Revenues | 8.40 | 3.21 | 2.52 | 10.72 | 7.81 |
| Total Operating Revenues | 2622.85 | 2177.41 | 1852.14 | 1490.84 | 1376.18 |
| | | | | | |
| Other Income | 70.38 | 50.42 | 59.31 | 41.85 | 6.69 |
| Total Revenue | 2693.22 | 2227.83 | 1911.45 | 1532.69 | 1382.88 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 753.02 | 667.70 | 612.97 | 540.67 | 419.76 |
| Purchase Of Stock-In Trade | 574.48 | 444.28 | 314.78 | 163.25 | 311.57 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -183.76 | -73.86 | -6.39 | 12.90 | -136.28 |
| Employee Benefit Expenses | 350.30 | 293.64 | 239.37 | 220.30 | 197.32 |
| Finance Costs | 11.66 | 11.20 | 9.13 | 8.45 | 7.99 |
| Depreciation And Amortisation Expenses | 83.39 | 74.27 | 51.85 | 44.78 | 36.15 |
| Other Expenses | 600.17 | 387.07 | 352.09 | 294.84 | 244.20 |
| Total Expenses | 2189.25 | 1804.30 | 1573.80 | 1285.18 | 1080.71 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 503.97 | 423.53 | 337.65 | 247.51 | 302.16 |
| | | | | | |
| Profit/Loss Before Tax | 503.97 | 423.53 | 337.65 | 247.51 | 302.16 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 127.28 | 113.31 | 71.57 | 57.10 | 66.69 |
| Deferred Tax | -7.24 | -5.11 | 1.10 | 3.59 | -3.07 |
| Tax For Earlier Years | 1.31 | 0.43 | -0.33 | 0.01 | 0.00 |
| Total Tax Expenses | 121.35 | 108.63 | 72.33 | 60.70 | 63.63 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 382.62 | 314.90 | 265.32 | 186.81 | 238.54 |
| | | | | | |
| Profit/Loss From Continuing Operations | 382.62 | 314.90 | 265.32 | 186.81 | 238.54 |
| | | | | | |
| Profit/Loss For The Period | 382.62 | 314.90 | 265.32 | 186.81 | 238.54 |
| | | | | | |
| Minority Interest | -2.04 | -1.20 | 0.99 | 0.00 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 380.58 | 313.70 | 266.31 | 186.81 | 238.54 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 8.40 | 6.92 | 6.41 | 4.51 | 5.76 |
| Diluted EPS (Rs.) | 8.40 | 6.92 | 6.41 | 4.51 | 5.76 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 27.19 | 22.66 | 10.17 | 10.23 | 4.09 |
